PGE2 production in oral cancer cell lines is COX-2-dependent

Journal of Dental Research

Volumn 88, Issue 2, 2009, Pages 164-169

  Husvik, C ^a   Khuu, C ^a   Bryne, M ^a   Halstensen, T S ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Immunohistofluorescence; Oral squamous cell carcinoma; Prostaglandin E2; siRNA

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR; ISOENZYME; ISOMERASE; PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; SMALL INTERFERING RNA;

AGED; ARTICLE; BIOSYNTHESIS; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENE SILENCING; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; MOUTH TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

AGED; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; ISOENZYMES; MALE; MIDDLE AGED; MOUTH NEOPLASMS; RNA, SMALL INTERFERING;

EID: 62649161864     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/0022034508329519     Document Type: Article

References (31)

1. Atula T, Hedstrom J, Ristimaki A, Finne P, Leivo I, Markkanen-Leppanen M, et al. (2006). Cyclooxygenase-2 expression in squamous cell carcinoma of the oral cavity and pharynx: association to p53 and clinical outcome. Oncol Rep 16:485-490.
2. Baratelli F, Lin Y, Zhu L, Yang SC, Heuze-Vourc'h N, Zeng G, et al. (2005). Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells. J Immunol 175:1483-1490.
3. Bosetti C, Gallus S, La Vecchia C (2006). Aspirin and cancer risk: an updated quantitative review to 2005. Cancer Causes Control 17:871-888. (Pubitemid 44081706)
4. Brenneis C, Maier TJ, Schmidt R, Hofacker A, Zulauf L, Jakobsson PJ, et al. (2006). Inhibition of prostaglandin E2 synthesis by SC-560 is independent of cyclooxygenase 1 inhibition. FASEB J 20:1352-1360. (Pubitemid 44943843)
5. Chan G, Boyle JO, Yang EK, Zhang F, Sacks PG, Shah JP, et al. (1999). Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 59:991-994. (Pubitemid 29135955)
6. Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, et al. (2002). COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 99:13926-13931. (Pubitemid 35215482)
7. Costea DE, Loro LL, Dimba EA, Vintermyr OK, Johannessen AC (2003). Crucial effects of fibroblasts and keratinocyte growth factor on morphogenesis of reconstituted human oral epithelium. J Invest Dermatol 121:1479-1486.
8. Dannenberg AJ, Lippman SM, Mann JR, Subbaramaiah K, DuBois RN (2005). Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention. J Clin Oncol 23:254-266. (Pubitemid 46206877)
9. Guarino M, Rubino B, Ballabio G (2007). The role of epithelial- mesenchymal transition in cancer pathology. Pathology (Phila) 39:305-318. (Pubitemid 46897605)
10. Gupta GP, Nguyen DX, Chiang AC, Bos PD, Kim JY, Nadal C, et al. (2007). Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 446:765-770. (Pubitemid 46582040)
11. Ingber DE (2002). Cancer as a disease of epithelial-mesenchymal interactions and extracellular matrix regulation. Differentiation 70:547-560.
12. Kino Y, Kojima F, Kiguchi K, Igarashi R, Ishizuka B, Kawai S (2005). Prostaglandin E2 production in ovarian cancer cell lines is regulated by cyclooxygenase-1, not cyclooxygenase-2. Prostaglandins Leukot Essent Fatty Acids 73:103-111. (Pubitemid 41008620)
13. Laufer S, Zechmeister P, Klein T (1999). Development of an in-vitro test system for the evaluation of cyclooxygenase-2 inhibitors. Inflamm Res 48:133-138. (Pubitemid 29137663)
14. Lim SC, Zhang S, Ishii G, Endoh Y, Kodama K, Miyamoto S, et al. (2004). Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue. Clin Cancer Res 10(1 Pt 1):166-172. (Pubitemid 38114175)
15. Lin DT, Subbaramaiah K, Shah JP, Dannenberg AJ, Boyle JO (2002). Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer. Head Neck 24:792-799. (Pubitemid 34857307)
16. Minter HA, Eveson JW, Huntley S, Elder DJ, Hague A (2003). The cyclooxy genase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis. Clin Cancer Res 9:1885-1897. (Pubitemid 36554617)
17. Murakami M, Naraba H, Tanioka T, Semmyo N, Nakatani Y, Kojima F, et al. (2000). Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem 275:32783-32792. (Pubitemid 30797052)
18. Murakami M, Nakashima K, Kamei D, Masuda S, Ishikawa Y, Ishii T, et al. (2003). Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2. J Biol Chem 278:37937-37947. (Pubitemid 37175324)
19. Nurmi JT, Puolakkainen PA, Rautonen NE (2005). Intron 1 retaining cyclooxygenase-1 splice variant is induced by osmotic stress in human intestinal epithelial cells. Prostaglandins Leukot Essent Fatty Acids 73:343-350.
20. Nystrom ML, McCulloch D, Weinreb PH, Violette SM, Speight PM, Marshall JF, et al. (2006). Cyclooxygenase-2 inhibition suppresses {alpha}v{beta}6 integrin-dependent oral squamous carcinoma invasion. Cancer Res 66:10833-10842. (Pubitemid 44876979)
21. Qin N, Zhang SP, Reitz TL, Mei JM, Flores CM (2005). Cloning, expression, and functional characterization of human cyclooxygenase-1 splicing variants: evidence for intron 1 retention. J Pharmacol Exp Ther 315:1298-1305. (Pubitemid 41635418)
22. Renkonen J, Wolff H, Paavonen T (2002). Expression of cyclo-oxygenase-2 in human tongue carcinoma and its precursor lesions. Virchows Arch 440:594-597. (Pubitemid 34809690)
23. Sakurai K, Urade M, Noguchi K, Hashitani S, Takaoka K, Segawa E, et al. (2007). Prognostic significance of cyclooxygenase-2 and DNA topoisomerase IIalpha expression in oral carcinoma. Head Neck 29:1002-1009.
24. Shibata M, Kodani I, Osaki M, Araki K, Adachi H, Ryoke K, et al. (2005). Cyclo-oxygenase-1 and -2 expression in human oral mucosa, dysplasias and squamous cell carcinomas and their pathological significance. Oral Oncol 41:304-312. (Pubitemid 40311759)
25. Smith CJ, Zhang Y, Koboldt CM, Muhammad J, Zweifel BS, Shaffer A, et al. (1998). Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci USA 95:13313-13318.
26. Soland TM, Husvik C, Koppang HS, Boysen M, Sandvik L, Clausen OP, et al. (2008). A study of phosphorylated ERK1/2 and COX-2 in early stage (T1-T2) oral squamous cell carcinomas. J Oral Pathol Med 37:535-542.
27. Tanioka T, Nakatani Y, Semmyo N, Murakami M, Kudo I (2000). Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J Biol Chem 275:32775-32782. (Pubitemid 30797051)
28. Thoren S, Jakobsson PJ (2000). Coordinate up- and down-regulation of glutathione-dependent prostaglandin E synthase and cyclooxygenase-2 in A549 cells. Inhibition by NS-398 and leukotriene C4. Eur J Biochem 267:6428-6434. (Pubitemid 30805115)
29. Thun MJ, Namboodiri MM, Heath CW Jr (1991). Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325:1593-1596.
30. Zha S, Yegnasubramanian V, Nelson WG, Isaacs WB, De Marzo AM (2004). Cyclooxygenases in cancer: progress and perspective. Cancer Lett 215:1-20.
31. Zhang Q, Adiseshaiah P, Kalvakolanu DV, Reddy SP (2006). A phosphatidylinositol 3-kinase-regulated Akt-independent signaling promotes cigarette smoke-induced FRA-1 expression. J Biol Chem 281:10174-10181. (Pubitemid 43864553)